Deloitte - Advancing Innovation from Abroad: Investing in Life Sciences in China and the UK

  • Thursday, 25 March 2021, 9:30 AM to 10:30 AM

Registration is now open for the next session in the Deloitte Life Sciences Catalyst virtual events programme, as part of thier goal to support connections between people, businesses and investors.

The programme continues with as Advancing Innovation from Abroad: Investing in Life Sciences in China and the UK webinar on 25 March 2021 at 09:30 GMT / 17:30 CST.

China is the world’s second largest healthcare market, with its pharmaceutical market predicted to be worth upwards of USD 150 billion by 2023. Traditionally UK life sciences companies have looked to the US for additional investment, but with China’s booming biotech industry new opportunities are opening up.

In this hour-long discussion the panellists will explore the following topics:

  • The background context of UK-China technology collaboration and the related geo-political scene
  • Chinese investment in the UK life sciences space, including drivers and hurdles to investment
  • Business opportunities in China for the UK life sciences industry, including considerations for entering the Chinese market and cross border value creation
  • UK investment in the Chinese life sciences sector, including what investors are looking for, the opportunities and pitfalls for investing in China

Delegates will also be given a brief introduction to the institutions represented by the panellists, and have an opportunity to ask questions of the speakers:

  • Peter Manning OBE, Executive Director, East of England China Forum
  • Jerry Wu, Head of Investment, TusPark Holdings UK
  • Chandler Chen, Director, I•Campus, AstraZeneca’s International Life Sciences Innovation Campus in China (a joint venture between AstraZeneca and the Wuxi City government)
  • Alan MacCharles, Partner, Financial Advisory, Deloitte
  • David Percival MBE, Managing Director, China Services Group, Deloitte

Please register via the link below.

Find out more from Deloitte

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.